ESR1 and osteoporosis: Those approved or under clinical trials that have shown beneficial effects on BMD in postmenopausal women with osteoporosis (e.g., raloxifene,382,383 lasofoxifene,384,385 bazedoxifene386) are ER agonists in bone.387,388